X-Vax Technology

X-Vax is a biotech company committed to developing vaccines against pathogens acquired by mucosal infection such as herpes.

Industries

Biotechnology

Headquarters

Jupiter, United States

Stage

Series A

Employees

1-10

Links

Org chart

Ulf Wiinberg
President & Chief Executive Officer
Collapse
Andreas Eggert
Chief Operating Officer
Katalin Abraham
Chief Regulatory & Preclinical Development Officer
Glenn Rockman
Director
Roger J. Pomerantz, MD, FACP
Founding Director, Board Of Directors

Teams

View all

+3

Board of Directors

6 members

+2

Leadership Team

5 members

CEO and Executive Team

3 members

Discover similar companies

Gameto

Series A • New York, United States

Neogene Therapeutics

Series A • New York, United States

Xontogeny

Series A • Boston, United States

Chroma Medicine

Series A • Cambridge, United States

Primmune Therapeutics

Series A • San Diego, United States

Kula Bio

Series A • Somerville, United States

Dianthus Therapeutics

Series A • Waltham, United States

Arcaea

Series A • Boston, United States

royal

Series A • Austin, United States

Callin

Series A • San Francisco, United States

Rewatch

Series A • San Francisco, United States

Opal

Series A • San Francisco, United States

The Org
helps you hire
great candidates
It takes less than ten minutes to set up your company page.
It’s free to use - try it out today.